Frontier Science

At the forefront of advancing research

[Frontier Science @Frontier_SF]

OlympiA Phase III trial of AstraZeneca and MSD’s Lynparza (Olaparib) moves to early primary analysis. Read more https://t.co/NyREu7tQyJ

[Frontier Science @Frontier_SF]

NIH has announced clinical investigators and institutions to lead four NIH HIV clinical trials networks over the next seven years. Frontier Science’s Marlene Cooper leads the DataManagement Center for the ACTG and IMPAACT networks. https://t.co/N8r98aMuIN

[Frontier Science @Frontier_SF]

Frontier Science featured in news article outlining how Buffalo research companies are attacking COVID-19
https://t.co/N8r98aMuIN

[Frontier Science @Frontier_SF]

Read our latest news Frontier Science Response to COVID-19: A Message From The CEO https://t.co/qT6IBr3DXW

[Frontier Science @Frontier_SF]

IMPAACT P1104s study finds neuropsychological challenges in children who acquire HIV early in life, highlighting a need to develop additional interventions according to a report published online in Clinical Infectious Diseases. https://t.co/N8r98aMuIN

[Frontier Science @Frontier_SF]

The National Cancer Institute awards a $12 million grant to the University of Wisconsin and Frontier Science Foundation https://t.co/N8r98aMuIN @NCIprevention